The Importance of Early Tumor Shrinkage and Deepness of Response in Assessing the Efficacy of Systemic Anticancer Treatment With Metastatic Colorectal Cancer

Klinicka Onkologie - Czech Republic
doi 10.14735/amko201589
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ambit Media, a.s.

Related search

Advances in the Treatment of Metastatic Colorectal Cancer

Disease-a-Month
Medicine
2010English

Transarterial Chemoembolisation in the Treatment of Patients With Metastatic Colorectal Cancer

I.P. Pavlov Russian Medical Biological Herald
2018English

Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer

Scientific Reports
Multidisciplinary
2019English

Assessing Efficacy and the Speed of Response in Psoriasis Treatment

Journal of Dermatological Treatment
Dermatology
2019English

Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2012English

Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival

Annals of Surgical Oncology
OncologySurgery
2019English

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy